EU regulators approve BioNTech-Pfizer COVID vaccine
The decision by European Medicines Agency may allow countries to begin vaccinating before the end of the year. The vaccine's approval was widely expected, as EU nations grapple with a worsening coronavirus second wave.
US experts recommend Pfizer Covid vaccine approval
US experts vote to recommend granting emergency approval for Pfizer-BioNTech's Covid-19 vaccine, paving the way for America to become the next country to move ahead with mass immunization as the country's virus death toll approaches 300,000. The US government's top infectious disease specialist Anthony Fauci also comments on the vaccine recommendation, saying "they are safe and they are highly effective, and those decisions were made by independent bodies without any political or other influence,".
Coronavirus: Pfizer, BioNTech apply for EU approval of vaccine
Pfizer and BioNTech have lodged their COVID-19 vaccine with the European Medicines Agency for conditional approval. The companies have already taken similar steps in the US and UK.
Pfizer-BioNTech COVID-19 vaccine 95% effective in final trial
Pfizer and BioNTec are preparing to submit their vaccine to US regulators for approval for emergency use. The two pharma firms claim the product is effective in 95% of the cases with no major safety concerns.
US pharma firm Moderna says its COVID-19 vaccine is 94.5% effective
Moderna said that Phase 3 stage analysis suggested its coronavirus vaccine could prevent COVID-19. The news comes a week after Pfizer and German drug-maker BioNTech announced a vaccine of their own.
Coronavirus: German company BioNTech says its vaccine is 90% effective
A vaccine jointly developed by German company BioNTech and US firm Pfizer has proven to be 90% effective at preventing COVID-19 infections, according to phase 3 trials.
Covid-19, Pfizer annonces early data shows its vaccine trial is more than 90% effective
Pfizer and BioNTech have chosen RNA messenger technology for their vaccine. It is made up of lab-made RNA strands containing the code for the same protein that allows coronavirus to enter cells.
#EndSARS protest disruption costs economy ₦1.5tn, claims Bismark Rewane and more
Here are a few reasons to pick up a copy of The Guardian on Tuesday. Find these stories and much more when you grab a copy of The Guardian on Tuesday.